- Home
- ORKA vs ARRY Comparison
ORKA vs ARRY Comparison
Compare ORKA & ARRY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ORKA
- ARRY
- Stock Information
- Founded
- ORKA 2004
- ARRY 1989
- Country
- ORKA United States
- ARRY United States
- Employees
- ORKA N/A
- ARRY N/A
- Industry
- ORKA Biotechnology: In Vitro & In Vivo Diagnostic Substances
- ARRY Semiconductors
- Sector
- ORKA Health Care
- ARRY Technology
- Exchange
- ORKA Nasdaq
- ARRY Nasdaq
- Market Cap
- ORKA 354.2M
- ARRY 785.6M
- IPO Year
- ORKA N/A
- ARRY 2020
- Fundamental
- Price
- ORKA $14.25
- ARRY $7.39
- Analyst Decision
- ORKA Strong Buy
- ARRY Buy
- Analyst Count
- ORKA 8
- ARRY 20
- Target Price
- ORKA $39.71
- ARRY $9.47
- AVG Volume (30 Days)
- ORKA 359.5K
- ARRY 10.9M
- Earning Date
- ORKA 08-15-2025
- ARRY 08-07-2025
- Dividend Yield
- ORKA N/A
- ARRY N/A
- EPS Growth
- ORKA N/A
- ARRY N/A
- EPS
- ORKA N/A
- ARRY N/A
- Revenue
- ORKA N/A
- ARRY $1,064,767,000.00
- Revenue This Year
- ORKA N/A
- ARRY $24.15
- Revenue Next Year
- ORKA N/A
- ARRY $13.19
- P/E Ratio
- ORKA N/A
- ARRY N/A
- Revenue Growth
- ORKA N/A
- ARRY N/A
- 52 Week Low
- ORKA $5.49
- ARRY $3.76
- 52 Week High
- ORKA $52.32
- ARRY $11.87
- Technical
- Relative Strength Index (RSI)
- ORKA N/A
- ARRY 55.44
- Support Level
- ORKA N/A
- ARRY $7.20
- Resistance Level
- ORKA N/A
- ARRY $7.92
- Average True Range (ATR)
- ORKA 0.00
- ARRY 0.46
- MACD
- ORKA 0.00
- ARRY 0.04
- Stochastic Oscillator
- ORKA 0.00
- ARRY 82.68
About ORKA Oruka Therapeutics Inc. Common Stock
Oruka Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing novel monoclonal antibody therapeutics for psoriasis (PsO) and other inflammatory and immunology (I&I) indications. Its lead program, ORKA-001, is designed to target the p19 subunit of interleukin-23 (IL-23p19) for the treatment of PsO. The company's co-lead program, ORKA-002, is designed to target interleukin-17A and interleukin-17F (IL-17A/F) for the treatment of PsO, psoriatic arthritis (PsA), and other conditions. These programs each bind their respective targets at high affinity and incorporate half-life extension technology to increase exposure and decreasing dosing frequency.
About ARRY Array Technologies Inc.
Array Technologies Inc manufacturer of ground-mounting systems used in solar energy projects. The company's segments include: the Array legacy operating segment (Array Legacy Operations) and the STI Operations operating segment (STI Operations). It derives maximum revenue from the Array legacy operating segment. Its product is an integrated system of steel supports, electric motors, gearboxes and electronic controllers referred to as a single-axis tracker that move solar panels throughout the day to maintain an optimal orientation to the sun, which increases their energy production. Geographically, the company's operations are in the United States, Australia, Spain, Brazil and Rest of the World with the United States deriving the majority of the revenue.